Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 223
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05860530 | Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers | ||
| NCT05801094 | A Phase I Study of QL1604 for Advanced Solid Tumors | ||
| NCT03169335 | Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer | ||
| NCT06880276 | Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis | ||
| NCT06742216 | Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study | ||
| NCT07061639 | A Study of QLS5133 Monotherapy in Advanced Solid Tumors | ||
| NCT06616571 | Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints | ||
| NCT05950516 | Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes | ||
| NCT06500507 | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT06649214 | A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia | ||
| NCT07302516 | Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma | ||
| NCT07345000 | A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia | ||
| NCT06932107 | Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting | ||
| NCT07040826 | Lifitegrast Eye Drops in Healthy Subjects：Phase I Study | ||
| NCT06403735 | A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors | ||
| NCT07416058 | PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC | ||
| NCT05629949 | A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer | ||
| NCT07487103 | Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes | ||
| NCT07081256 | To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy. | ||
| NCT06173011 | A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults | ||
| NCT05648669 | A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain | ||
| NCT07444086 | QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia | ||
| NCT05884801 | Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors | ||
| NCT07138833 | A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) | ||
| NCT03557580 | A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects | ||
| NCT07377773 | QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis | ||
| NCT07463573 | QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma | ||
| NCT07453394 | QLS5132 Combination Therapy in Advanced Solid Tumors | ||
| NCT06954246 | A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer | ||
| NCT06942767 | Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | ||
| NCT06456528 | QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia | ||
| NCT05621330 | Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia | ||
| NCT07151872 | Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer | ||
| NCT05108779 | QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors | ||
| NCT05823246 | Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma | ||
| NCT06058000 | A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis | ||
| NCT04705519 | Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma | ||
| NCT04550949 | To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors | ||
| NCT07127822 | Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT04864782 | QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer | ||
| NCT03244085 | A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients | ||
| NCT06864793 | Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers | ||
| NCT04296994 | A Study of QL1706 in Subjects With Advanced Malignant Tumor | ||
| NCT07152444 | A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension | ||
| NCT03750916 | Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer | ||
| NCT05823285 | A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients | ||
| NCT02335879 | Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation | ||
| NCT05799820 | QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC | ||
| NCT07173595 | A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies |
